eculizumab (Soliris) Report issue

Biologics mAb Orphan Drug FDA Approved FDA First in Class Priority Review FDA
Back

Drug Pricing Summary

AUS PBS

$4373.1804

VA Big4

$4981.6100

VA FSS

$6031.3200

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
eculizumab 300 mg / 30 mL (30 mL INJECTION) $4373.1804 AUS PBS generic
  • Soliris (1)
  • Alexion Pharmaceuticals Australasia Pty Ltd
    eculizumab 300 mg / 30 mL (30 mL INJECTION) $4981.6100 VA Big4
  • SOLIRIS (1)
  • Alexion Pharmaceuticals Inc.
    eculizumab 300 mg / 30 mL (30 mL INJECTION) $6031.3200 VA FSS
  • SOLIRIS (1)
  • Alexion Pharmaceuticals Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue